U.S. markets closed
  • S&P 500

    3,369.02
    +58.78 (+1.78%)
     
  • Dow 30

    27,480.03
    +554.98 (+2.06%)
     
  • Nasdaq

    11,160.57
    +202.96 (+1.85%)
     
  • Russell 2000

    1,614.30
    +45.70 (+2.91%)
     
  • Crude Oil

    38.15
    +1.34 (+3.64%)
     
  • Gold

    1,910.50
    +18.00 (+0.95%)
     
  • Silver

    24.29
    +0.26 (+1.07%)
     
  • EUR/USD

    1.1722
    +0.0079 (+0.68%)
     
  • 10-Yr Bond

    0.8820
    +0.0330 (+3.89%)
     
  • GBP/USD

    1.3066
    +0.0148 (+1.15%)
     
  • USD/JPY

    104.4870
    -0.2330 (-0.22%)
     
  • BTC-USD

    13,685.05
    +177.78 (+1.32%)
     
  • CMC Crypto 200

    264.84
    +4.18 (+1.60%)
     
  • FTSE 100

    5,786.77
    +131.80 (+2.33%)
     
  • Nikkei 225

    23,295.48
    +318.35 (+1.39%)
     

Exact Sciences Corp (EXAS) President and CEO Kevin T Conroy Sold $4 million of Shares

GuruFocus.com
·1 min read

- By insider

President and CEO of Exact Sciences Corp (30-Year Financial, Insider Trades) Kevin T Conroy (insider trades) sold 32,819 shares of EXAS on 11/02/2020 at an average price of $121.11 a share. The total sale was $4 million.


Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer. Exact Sciences Corp has a market cap of $18.98 billion; its shares were traded at around $126.15 with and P/S ratio of 14.04. Exact Sciences Corp had annual average EBITDA growth of 6.20% over the past five years. GuruFocus has detected 2 severe warning signs with Exact Sciences Corp. .

CEO Recent Trades:

  • President and CEO Kevin T Conroy sold 32,819 shares of EXAS stock on 11/02/2020 at the average price of $121.11. The price of the stock has increased by 4.16% since.

For the complete insider trading history of EXAS, click here

.This article first appeared on GuruFocus.